PubMed Health⌕ Search

Biomedical subjects

M Bueno

Publications and source records attributed to M Bueno.

At least 19 recordsLinked to original sources
PubMed1994

Sclerosteosis in a Spanish male: first report in a person of Mediterranean origin.

We report the first observation of sclerosteosis in Spain. To the best of our knowledge, this is the first case of sclerosteosis in a person of Mediterranean origin with no known Dutch ancestors. He has the characteristic phenotype of the disease with right facial nerve palsy and syndactyly and the typical radiological features, including generalised bone sclerosis and cortical widening of the tubular bones.

Adolescent↗
PubMed1994

[The costs for a health center in relation to its activities].

OBJECTIVE: To establish a system of attributing costs of Health Centres (HC) in the Primary Care network in function of health care activity. DESIGN: Crossover study with a descriptive component. SETTING: Management. Primary Care. PATIENTS OR OTHER PARTICIPANTS: 22 Health Centres open during December 1991 within the Health Area. MEASUREMENTS AND MAIN RESULTS: Two groups for cost attribution per Health Centre were agreed: articles from Chapter II relating to health care activity and Pharmacy spending-->costs relating to activity (CRA); the remaining articles from Chapter II and Chapter I (staff payments)-->costs not relating to activity (CNRA). Costs relating to activity made up 62.51% of the total cost per HC (2.72% articles from Chapter II and 59.79% Pharmacy). The remaining 37.49% corresponded to costs not relating to activity (1.38% to the remaining articles from Chapter II and 36.11% to staff payments). CONCLUSIONS: We consider that the attribution of costs in function of the activity per HC is useful for the planning and management of Area resources and assists the application of efficiency criteria in Health Centres.

Community Health Centers↗
PubMed1993

Congenital hemihypertrophy.

We present an isolated complete left hemihypertrophy in a girl with follow-up data from birth up to the age of 5 months.

Anthropometry↗
PubMed1992

Usefulness of serum apolipoprotein B levels for screening children with primary dyslipoproteinemias.

OBJECTIVE: To assess the use of serum apolipoprotein B levels for screening children with primary dyslipoproteinemia (those with elevated levels of low-density lipoprotein cholesterol [LDL-C]) and to know the types of dyslipoproteinemias we can identify. DESIGN: Criterion standard. SETTING: Referral center. PARTICIPANTS: We have studied 267 children. Of these, 31 had parents with dyslipoproteinemia, 38 had parents with ischemic heart disease, and 43 had hypercholesterolemia detected by routine analyses. One hundred fifty-five were considered healthy children and comprised the control group. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Sensitivity was 87% for total serum cholesterol levels and 73% for serum apolipoprotein B levels. Of the children studied, 31 had elevated levels of serum LDL-C. The types of dyslipoproteinemia in children with both elevated levels of serum LDL-C and apolipoprotein B consisted of heterozygous familial hypercholesterolemia, found in 12 (50%) of 24 patients; familial combined hyperlipidemia, found in 11 (46%) of 24 patients; and polygenic hypercholesterolemia, found in one (4%) of 24 patients. CONCLUSIONS: Serum apolipoprotein B level appears to be a good tool for screening children with elevated levels of LDL-C and is equivalent to using total serum cholesterol levels. In children with elevated serum LDL-C and apolipoprotein B levels, we can identify not only patients with heterozygous familial hypercholesterolemia but also those with familial combined hyperlipidemia or polygenic hypercholesterolemia.

Adolescent↗